Skip to main content
. 2016 Jul 1;12:1617–1621. doi: 10.2147/NDT.S106123

Table 3.

Latencies to find the platform in different groups (mean ± SD, n=10)

Groups Latency (s)
Before treatment Posttreatment
Control 45.44±2.45 47.21±2.33
DM 83.11±5.13* 86.35±4.77*,
Piracetam 74.32±4.34* 44.23±4.54*,
Low dose of APS 71.11±2.37* 43.66±4.55*,
Medium dose of APS 73.67±4.24* 42.45±4.23*,
High dose of APS 70.56±3.33* 40.34±3.21*,

Notes:

*

P=0.0014<0.05 compared with the control;

P=0.0000<0.05 compared with the model group.

Abbreviations: APS, Astragalus polysaccharides; DM, diabetes mellitus; SD, standard deviation.